Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision entry (Revision: v3.5.5) has been added along with new dates (2026-06-03, 2026-12-18, 2026-05-08, 2026-05). The previous revision (v3.5.4) was removed, signaling an update to IPD sharing materials and related study documents.
    Difference
    0.2%
    Check dated 2026-06-08T17:52:14.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a new Revision: v3.5.4 tag replacing the previous v3.5.3, indicating a minor update to the document version. This reflects metadata refresh rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-05-18T04:01:05.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The Taiwan site listing changes from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333. This clarifies the city designation in the Locations list, aiding accurate site identification and search filters.
    Difference
    0.0%
    Check dated 2026-05-03T14:01:43.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site/version update rather than a change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-26T08:10:15.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a version bump with no changes to study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-04-19T01:30:28.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    - Adds hepatocellular carcinoma as a topic on the page. Introduces a Genetic and Rare Diseases Information Center resource and updates the revision to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:45:15.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.